Alinity i Anti-TPO Reagent Kit
Recall Z-1696-2023, part of FDA recall event 92271. See Abbott Ireland's company page.
Abbott Ireland Limited started this Class III device recall on Apr 24, 2023 (voluntary: firm initiated); FDA lists it as ongoing.
- Classification: Class III
- Started: Apr 24, 2023
- Status: Ongoing
Due to a manufacturing fill volume error, Alinity i Anti-TPO Reagent contains a marginally lower fill volume than detailed in the Kit Contents section of the Instructions for Use (IFU).
- Product
- Alinity i Anti-TPO Reagent Kit, List Number 09P3521
- Quantity
- 110 kits
- Lots and codes
- UDI Number: (01)00380740153892(17)240720(10)46009FN00; List Number: 09P3521; Lot Number: 46009FN00; Expiration Date: 07/20/2024
- Distribution
- US Nationwide distribution in the states of CA, CO, FL, GA, IL, KY, LA, MD, MI, MN, NJ, NY, OH, RI, SC, SD, TN, TX, WA. No international distribution of affected lot.
- Recalling firm
- Abbott Ireland Limited, Sligo, Ireland
- How the firm notified
- Letter
- FDA classified
- Jun 8, 2023
FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA device enforcement reports